Ads by Google
FDA approved the Endeavor Zotarolimus-Eluting Coronary Stent for use in treating patients with narrowed coronary arteries, the blood vessels supplying the heart.
Edwards Lifesciences has received conditional approval from FDA for a revised design to US pivotal clinical trial of the Edwards SAPIEN transcatheter aortic heart valve technology.
Researchers found that coronary magnetic resonance angiography is better than 64-slice computed tomography angiography at detecting narrowing arteries in the heart, thus enabling the identification of patients with the greatest risk for heart disease.
Center for Integrative Medicine, Bluhm Cardiovascular Institute of Northwestern Memorial Hospital have joined forces to offer a new approach to prevention of heart disease.
A new stent with a nanothin surface application shows promise in opening and healing blocked heart arteries without the life-threatening dangers of drug-eluting stents.
Patent expiries of key therapies will cause the chronic heart failure drug market to decline by more than 50%.
NitroMed plans to end sales and promotional activities of the congestive heart failure medication BiDil.
In the quest to discover how the mechanisms of disease work, researchers have run the largest mathematical simulation of a heart ever assembled on a high-performance computing system from SGI.
Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer. But as their hearts decline into congestive heart failure, an increasing number will experience disability and the need for nursing-home care.
A new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System sheds light on the degree of disability among people with CHF, as well as the implications for the health care system, community care facilities, families and the patients themselves.
People with restless legs syndrome are twice as likely to have a stroke or heart disease.
Older women heart patients benefit from educational programs as a supplement to clinical care to help significantly lower cardiac symptoms, lose weight and increase physical activity.
A study found that delayed defibrillation was associated with lower rates of survival after in-hospital cardiac arrest.
Medical Simulation Corporation launches Edwards SAPIEN Transcatheter Heart Valve Training Program in Europe.
Ferring Pharmaceuticals announced a new, improved cost-saving program for heart patients who are considering fertility treatment, but find the costs a challenge.
For every 100 uninsured people with heart disease or diabetes before age 65, we found that with Medicare coverage they had 10 fewer major cardiac complications.
Hospitals in almost one-third of sudden cardiac arrest cases do not defibrillate patients in the recommended time, and such delays increase their risk for brain damage and death.
Only 30 percent of patients receive life-saving cardiac defibrillation more than two minutes after cardiac arrest
First national study of death risks from congenital heart repair suggests that the trickiest cases should go to regional centers.
Good Samaritan Initiative provides more affordable reconnection terms to Low Income Heat and Energy Assistance Program recipients who have had their utility services disconnected.
In cases of Type 1 myotonic muscular dystrophy (DM1), a well known heart protein does several surprising things.
Women are more likely to die from cardiovascular disease than all cancers combined.
ATS Medical announced FDA approval for the ATS Open Pivot AP360 Mechanical Heart Valve.
Most experienced hospitals provider better heart treatments to babies who need congenital heart repair.
Heart Savior was designed for the many causes of heart disease all in one Natural product.